Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, et al.
Science Advances (2020) Vol. 6, Iss. 50
Open Access | Times Cited: 234

Showing 26-50 of 234 citing articles:

Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome
Kiran Iqbal Masood, Maliha Yameen, Javeria Ashraf, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 75
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
Michael J. Ombrello, Grant S. Schulert
Translational research (2021) Vol. 232, pp. 1-12
Open Access | Times Cited: 67
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS
Aartik Sarma, Stephanie A. Christenson, Ashley Byrne, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 62
Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery
Siddharth Sridhar, John Nicholls
Respirology (2021) Vol. 26, Iss. 7, pp. 652-665
Open Access | Times Cited: 58
COVID-19 disease and immune dysregulation
Ethan Davitt, Colin Davitt, Monty B. Mazer, et al.
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101401-101401
Open Access | Times Cited: 50
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection
Noah J. Silverstein, Yetao Wang, Zachary Manickas-Hill, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 45
Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation
Rick Xing Ze Lu, Benjamin Lai, Naimeh Rafatian, et al.
Lab on a Chip (2022) Vol. 22, Iss. 6, pp. 1171-1186
Open Access | Times Cited: 42
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
Laura M. Palma Medina, Haris Babačić, Majda Dzidic, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23
De novo design of miniprotein antagonists of cytokine storm inducers
Buwei Huang, Brian Coventry, Marta T. Borowska, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Aging triggers an upregulation of a multitude of cytokines in the male and especially the female rodent hippocampus but more discrete changes in other brain regions
Latarsha Porcher, Sophie Bruckmeier, Steven D. Burbano, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 53
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
Michal A. Stanczak, David E. Sanin, Petya Apostolova, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Invasive pulmonary aspergillosis associated with viral pneumonitis
Intan Mauli Warma Dewi, Nico Janssen, Diletta Rosati, et al.
Current Opinion in Microbiology (2021) Vol. 62, pp. 21-27
Open Access | Times Cited: 51
Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation
Benjamin Bonnet, Justine Cosme, Claire Dupuis, et al.
EBioMedicine (2021) Vol. 73, pp. 103622-103622
Open Access | Times Cited: 51
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients
Jonathan Youngs, Nicholas M. Provine, Nicholas Lim, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 9, pp. e1009804-e1009804
Open Access | Times Cited: 49
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1)
José Alberto Choreño-Parra, Luis Jiménez-Álvarez, Alfredo Cruz‐Lagunas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
T. Matsuyama, Steven K. Yoshinaga, Kimitaka Shibue, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 12, pp. 3199-3213
Open Access | Times Cited: 47
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
Lina Ma, Sanjaya Kumar Sahu, Marlene Cano, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46
Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients
Jeremy D. Ward, Caleb Cornaby, John L. Schmitz
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 10
Open Access | Times Cited: 41
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
Ivan Zanoni
Current Opinion in Virology (2021) Vol. 50, pp. 119-127
Open Access | Times Cited: 41
A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections
Sarah C. Vick, Marie Frutoso, Florian Mair, et al.
Science Advances (2021) Vol. 7, Iss. 46
Open Access | Times Cited: 40
Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza
Demi Brownlie, Inga Rødahl, Renata Varnaitė, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Areez Shafqat, Shameel Shafqat, Sulaiman Al Salameh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2242-2242
Open Access | Times Cited: 27
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19
Heike C. Hawerkamp, Adam H. Dyer, Neha D. Patil, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19

Scroll to top